Parr Mcknight Wealth Management Group LLC Sells 4,645 Shares of Aflac Incorporated (NYSE:AFL)

Parr Mcknight Wealth Management Group LLC decreased its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 8.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 49,955 shares of the financial services provider's stock after selling 4,645 shares during the period. Parr Mcknight Wealth Management Group LLC's holdings in Aflac were worth $5,554,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Golden State Wealth Management LLC raised its position in shares of Aflac by 121.9% during the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after acquiring an additional 167 shares during the last quarter. Curio Wealth LLC bought a new stake in shares of Aflac during the 4th quarter valued at $36,000. Garde Capital Inc. bought a new stake in shares of Aflac during the 1st quarter valued at $36,000. Capital A Wealth Management LLC bought a new stake in shares of Aflac during the 4th quarter valued at $38,000. Finally, NBC Securities Inc. bought a new stake in shares of Aflac during the 1st quarter valued at $44,000. Institutional investors own 67.44% of the company's stock.

Aflac Stock Performance

NYSE AFL opened at $101.70 on Thursday. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $54.98 billion, a price-to-earnings ratio of 15.89, a P/E/G ratio of 3.20 and a beta of 0.81. The firm's 50 day simple moving average is $103.89 and its 200 day simple moving average is $105.25. Aflac Incorporated has a 1 year low of $88.70 and a 1 year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same quarter in the prior year, the business earned $1.66 EPS. The business's quarterly revenue was down 37.5% on a year-over-year basis. As a group, research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were issued a dividend of $0.58 per share. The ex-dividend date was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.28%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on AFL shares. Keefe, Bruyette & Woods boosted their price target on shares of Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a report on Wednesday, May 7th. Wall Street Zen downgraded shares of Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. UBS Group upped their target price on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Barclays set a $98.00 price target on shares of Aflac and gave the company an "underweight" rating in a report on Monday. Finally, Morgan Stanley increased their price target on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $106.93.

Insider Transactions at Aflac

In related news, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the sale, the director directly owned 6,728 shares of the company's stock, valued at $711,149.60. The trade was a 29.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the sale, the director directly owned 26,096 shares of the company's stock, valued at $2,786,791.84. The trade was a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 40,750 shares of company stock worth $4,304,295. Company insiders own 0.90% of the company's stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.